China today conditionally approved the domestic use of the drug for the treatment of COVID-19 in infected patients commonly used in the treatment of HIV.
The National Medical Products Administration (NMPA) has approved the use of the pill. Avudin as a new oral treatment option for adults against coronavirus.
People who suffer from COVID-19 “normal type” considered in China for example, one that has signs of pneumonia, even if patients have not reached a serious stage, will benefit from this decision according to the NMPA statement.
The regulatory move expands the use of this drug from Chinese pharmaceutical company Genuine Biotech, which was approved last July to treat people infected with the coronavirus. HIV.
China wants to get rid of the coronavirus
Asian giantclinging to a strict “Zero dynamic covid” policy that excludes life with virusseeks to increase the availability of vaccines and effective treatments against coronavirus.
The measures taken under this policy aim to eliminate all outbreaks, no matter how small, and are aided by mass testing and strict quarantine, with the most severe case illustrated quarantine metropolis of Shanghai (26 million inhabitants) for more than two months.
In addition to the innumerable economic lossesThese harsh measures also caused for the first time visible signs of irritation and discontent among the population, which has so far largely supported the government’s policy.
National Health Commission China The number of infections for the entire pandemic is 228,798 and the death toll is 5,226, although these figures do not include the thousands of asymptomatic cases reported in recent months.
EFE
Source: RPP
I’m Liza Grey, an experienced news writer and author at the Buna Times. I specialize in writing about economic issues, with a focus on uncovering stories that have a positive impact on society. With over seven years of experience in the news industry, I am highly knowledgeable about current events and the ways in which they affect our daily lives.